Vonoprazan
Selleck Chemicals
SKU:E7004-50MG
Couldn't load pickup availability

Vonoprazan is an inhibitor of Proton Pump used in studies of transporter biology. In practice, this places the compound in experiments that measure substrate uptake, efflux, and membrane-transport control in cardiovascular and metabolism models. Dose-response comparison, orthogonal validation, and secondary assay follow-up can further sharpen mechanistic interpretation.
By inhibiting Proton Pump, Vonoprazan can be used to examine substrate uptake, efflux, and membrane-transport control. This target class is commonly examined through transport, uptake/efflux, and permeability assays, together with downstream-response mapping. In cardiovascular and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Proton Pump
- Concentration-response inhibition and target-dependence studies
- Transport, uptake/efflux, and permeability assays
- Phenotypic profiling in cardiovascular and metabolism models
Overall, Vonoprazan is appropriate when a defined chemical perturbant is needed to connect Proton Pump with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Proton Pump
- Target Class:
- Transporter
- Research Area:
- Cardiovascular • Metabolism
- CAS No.:
- 881681-00-1
- Molecular Weight:
- 345.39
- Formula:
- C₁₇H₁₆FN₃O₂S
- PubChem:
- 15981397
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.